Blaine Pharmaceuticals Launches ReliaDose(R) Medicine Delivery System

CINCINNATI, May 2 /PRNewswire/ -- Blaine Pharmaceuticals today introduced ReliaDose, a unique medicine delivery system for babies. Invented by a mom, ReliaDose features a unique, patented dual-chamber nipple that masks the taste of medicine while ensuring safe, accurate dosing every time. ReliaDose is recommended for babies 0-18 months.

ReliaDose works with a baby’s natural desire to feed, providing an easy and accurate way to give medicine to a baby. It can ensure complete and gentle dosing of over-the-counter and prescribed liquid medication, as well as for liquid vitamin and mineral supplementation. Each dose is delivered with, but completely separate from, other fluids taken from the advanced bottle and patented dual-chamber nipple system. Designed for accuracy and ease of use, ReliaDose is a medicine delivery system that works for both babies and their caregivers.

“Giving medicine to a baby is an age-old problem for parents, especially new moms,” said Dreama Kirby, chief marketing officer, Blaine Pharmaceuticals. “ReliaDose is the perfect solution because it masks the taste of the medicine while ensuring accurate dosing.”

ReliaDose features a complete, patented system, including a dual-chamber nipple, bottle, and dosing syringe. The dual-chamber nipple allows medication to be delivered directly to the child’s mouth, improving medication acceptance, while the syringe allows for medicine to be given at a comfortable rate and ensures the right amount of medicine has been delivered. Because the medicine doesn’t mix with bottle contents, ReliaDose allows medication to be delivered without dilution or contamination.

“ReliaDose takes the stress out of giving medicine to your baby because you control the dosing while your baby feeds naturally,” added Kirby. “ReliaDose can also be used with what your baby likes to drink, so it fits into the baby’s normal routine.”

Blaine Pharmaceuticals will support the launch of ReliaDose with a national consumer advertising and public relations campaign this fall. Consumer marketing efforts will consist of print advertising, sampling, direct mail, e-marketing, as well as a comprehensive mix of retail promotions and consumer couponing to encourage trials. ReliaDose retails from $8.99-$11.99 and will be available at major grocers, drug stores, and mass merchandise locations throughout the United States. Blaine Pharmaceuticals will also reach out to healthcare professionals through educational and promotional programs that highlight how ReliaDose can provide a solution to a universal concern -- inaccurate dosing.

About Blaine Pharmaceuticals

Blaine Pharmaceuticals, founded in 1955, specializes in the development and acquisition of consumer brands with significant value and unrealized potential. Blaine builds sustainable brands by creating consumer demand through recommendations from healthcare professionals. The company’s flagship product, Mag-Ox 400(R), is one of the most recommended magnesium supplements by healthcare professionals. Other products include the DiaSense(R) family of nutritional supplements, and ReliaDose(R), a pediatric medicine delivery system.

Blaine is committed to cultivating relationships with physicians, pharmacists, patients, wholesalers, retailers, and business partners to build brands and lay the foundation for future endeavors. For more information, visit http://www.blainepharma.com.

Blaine Pharmaceuticals

CONTACT: Dreama Kirby of Blaine Pharmaceuticals, +1-859-344-9600, Ext. 15,dkirby@blainepharma.com

MORE ON THIS TOPIC